(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SEMPECTO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

SEMPECTO

ST13

US500000079395817

Class

5

Filing

79395817

Registration

7592830

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

11/01/2025

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

02/26/2024

Registration date

12/10/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/10/2024

Last transaction

11/01/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

ROACH,APRIL K

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Novartis AG

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma.

Publications

History of USPTO decisions and trademark events.

20 publications found

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

10/31/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/15/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

10/15/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/09/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/10/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/10/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/08/2024

PUBO

PUBLISHED FOR OPPOSITION

10/08/2024

NPUB

NOTICE OF PUBLICATION

09/18/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/03/2024

DOCK

ASSIGNED TO EXAMINER

08/29/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

05/29/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/29/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/29/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/29/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/29/2024

MAFR

APPLICATION FILING RECEIPT MAILED

05/24/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/24/2024

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

05/20/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/16/2024

Continuous trademark protection

Get notified about every new filing that threatens SEMPECTO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.